The data layer underneath an agentic system must handle variable schemas, vector embeddings, real-time retrieval, and ...
Sandisk (SNDK) analysis: ultra-low forward PEG, tight NAND supply and data-center demand vs projected EPS decline by FY2029.
The same family of artificial intelligence that powers today's image generators is now being aimed at one of biology's ...
Submission based on results of APEX pivotal trial which demonstrated bezuclastinib objective response rate (CR+CRh+PR+CI) of ...
World: Global premium pool expanded by +7.1% in 2025 – an increase of EUR456bn Singapore: Strong growth of +10.7% – due to ...
Submission based on results of APEX pivotal trial which demonstrated bezuclastinib objective response rate (CR+CRh+PR+CI) of 65% per mIWG criteria and 81% ORR per PPR criteria with a well-tolerated sa ...
H. Lundbeck A/S (Lundbeck) today announced preliminary Phase II Part A data from its ongoing study evaluating asedebart (Lu AG13909), an anti-adrenocorticotropic hormone (ACTH) monoclonal antibody, in ...
PHOENIX (AZFamily) — State leaders announced Tuesday that they reached a budget deal, ending months of negotiations three weeks ahead of their deadline. The agreement includes a moratorium on data ...
Bacteriophages, which infect bacterial cells, have a unique ability to reduce bacterial colonization, particularly in antibiotic-resistant biofilm infections. This study aims to fabricate optimized ...
– IDEAL Evaluated Livdelzi in People Living with PBC with Elevated ALP Levels (1-1.67xULN) on or Intolerant to UDCA – – 52-Week Results Demonstrate High and Sustained ALP Normalization and Generally ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced positive results from a Phase 3 study in people with primary biliary cholangitis (PBC), showing that ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Denver developer is planning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results